What is Corlanor
Approved as Treatment by the FDA
Ivabradine, also known as Corlanor, is approved by the FDA for 1 uses which include Left Ventricular Dysfunction .Effectiveness
When to interrupt dosage
The proposed dosage of Corlanor is contingent on the detected disorder, for example Chronic Stable Angina Pectoris, chronic, stable, symptomatic Heart Failure and Congestive Heart Failure. The measure of dosage is also governed by the technique of delivery (e.g. Tablet, film coated or Tablet, film coated - Oral) indicated in the table below.Warnings
Corlanor ContraindicationsCorlanor Novel Uses: Which Conditions Have a Clinical Trial Featuring Corlanor?
20 active clinical trials are investigating the potential of Corlanor for alleviating chronic, stable, symptomatic Heart Failure, Cardiomyopathy, Dilated and Systolic Dysfunction.Corlanor Reviews: What are patients saying about Corlanor?
Patient Q&A Section about corlanor
What is the drug Corlanor used for?
"Corlanor lowers the heart rate for people with chronic heart failure." - Anonymous Online Contributor
What does Corlanor do for the heart?
"Corlanor is a medication that is used to slow down the heart rate by affecting the electrical activity of the heart. It is used in adults with chronic heart failure, in order to lower the risk of being hospitalized when symptoms worsen." - Anonymous Online Contributor
What are the side effects of Corlanor?
"The following side effects have been reported by adults during Corlanor's post-approval use: fainting, low blood pressure, a type of irregular heart beat called torsade de pointes, sudden uncontrolled whole-body shaking (ventricular fibrillation), a fast heart rate (ventricular tachycardia), swelling under the skin (angioedema), redness of the skin (erythema), rash, itching (pruritus), hives (urticaria), dizziness (vertigo), and double vision (diplopia), as well as visual impairment." - Anonymous Online Contributor
What type of drug is Corlanor?
"Corlanor is a class of hyperpolarization-activated cyclic nucleotide-gated channel blockers that was FDA-approved in 2015. It helps to slow the heart rate, and has less effect on lowering blood pressure than other medications designed for the same purpose such as beta blockers." - Anonymous Online Contributor